By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


Drug Discovery

Company News
Can-Fite BioPharma (CFBI) Release: Second Part Of The Glaucoma Phase 2 Study Has Been Approved In A European Country 12/15/2014 7:42:18 AM
Can-Fite BioPharma (CFBI) To Initiate The Development Program Of Its Next Generation Drug Cf602 12/9/2014 7:36:12 AM
Can-Fite BioPharma (CFBI) Announces $8 Million At-The-Market Registered Direct Offering 12/2/2014 2:28:46 PM
Can-Fite BioPharma (CFBI) Reports Financial Results For Nine Months Ended September 30, 2014 12/2/2014 10:57:59 AM
Can-Fite BioPharma (CFBI) Release: U.S. Researchers Published Scientific Findings That Are A Potential Breakthrough For Prevention Of Neuropathic Pain By CF101 12/2/2014 10:50:40 AM
Can-Fite BioPharma (CFBI) Near-Term Milestones Timetable For 2014/2015 11/18/2014 4:59:26 PM
Can-Fite BioPharma (CFBI) Announces Special General Meeting Of Shareholders To Elect External Director 11/17/2014 4:14:22 PM
Can-Fite BioPharma (CFBI) CEO Dr. Pnina Fishman To Present Recently Released Positive Data From Its Rheumatoid Arthritis Phase 2b Study At The 2014 Can-Fite BioPharma (CFBI) Annual Meeting 11/13/2014 9:03:54 AM
Can-Fite BioPharma (CFBI) To Participate In Biotechnology Industry Organization (BIO)-Europe International Partnering Conference 10/30/2014 8:52:37 AM
Can-Fite BioPharma (CFBI) CEO Dr. Pnina Fishman To Co-Chair And Present At The 19th World Congress On Advances In Oncology's Cancer Therapeutics Session 10/7/2014 8:54:54 AM